Scholars@Duke

Table S7 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Publication ,  Other
Paller, CJ; Zahurak, ML; Mandl, A; Metri, NA; Lalji, A; Heath, E; Kelly, WK; Hoimes, C; Barata, P; Taksey, J; Garrison, DA; Patra, K ...
September 25, 2024
Published version (DOI) Publisher Link

<p>Table S7 shows Serious Adverse Events (N = 11 patients), by Type and Grade. Attributions Assigned Docetaxel versus HDIVC or Placebo</p>

Duke Scholars

Christopher Hoimes
Author Christopher Hoimes Medicine, Medical Oncology

DOI

10.1158/2767-9764.27101863

Publication Date

September 25, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paller, C. J., Zahurak, M. L., Mandl, A., Metri, N. A., Lalji, A., Heath, E., … Levine, M. (2024). Table S7 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. https://doi.org/10.1158/2767-9764.27101863
Paller, Channing J., Marianna L. Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth Heath, William K. Kelly, et al. “Table S7 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial,” September 25, 2024. https://doi.org/10.1158/2767-9764.27101863.
Paller CJ, Zahurak ML, Mandl A, Metri NA, Lalji A, Heath E, Kelly WK, Hoimes C, Barata P, Taksey J, Garrison DA, Patra K, Milne GL, Anders NM, Nauroth JM, Durham JN, Marshall CH, Markowski MC, Eisenberger MA, Antonarakis ES, Carducci MA, Denmeade SR, Levine M. Table S7 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. 2024.

DOI

10.1158/2767-9764.27101863

Publication Date

September 25, 2024